Cy­tori shares surge on mixed re­sults for its PhI erec­tile dys­func­tion study

Shares of San Diego-based Cy­tori Ther­a­peu­tics $CYTX bumped high­er Mon­day morn­ing on some mixed da­ta for its re­gen­er­a­tive cell ther­a­py aimed at erec­tile dys­func­tion among …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER